Cystic fibrosis and race

Cystic fibrosis transmembrane conductance regulatory (CFTR) protein.
Cystic fibrosis transmembrane conductance regulatory (CFTR) protein.

Underrepresented populations, especially black and hispanic populations with cystic fibrosis are often not successfully diagnosed.[1] This is in part due to the minimal dissemination of existing data on patients from these underrepresented groups. While white populations do appear to experience a higher frequency of cystic fibrosis, other ethnicities are also affected and not always by the same biological mechanisms.[2] Thus, many healthcare and treatment options are less reliable or unavailable to underrepresented populations. This issue affects the level at which public health needs are being met across the world.

  1. ^ Stewart, Cheryl; Pepper, Michael S. (2016). "Cystic fibrosis on the African continent". Genetics in Medicine. 18 (7): 653–662. doi:10.1038/gim.2015.157. hdl:2263/56176. ISSN 1530-0366. PMID 26656651. S2CID 3675593.
  2. ^ Tishkoff, Sarah A.; Kidd, Kenneth K. (November 2004). "Implications of biogeography of human populations for 'race' and medicine". Nature Genetics. 36 (11): S21–S27. doi:10.1038/ng1438. ISSN 1546-1718. PMID 15507999. S2CID 1500915.

Developed by StudentB